Delivery Order 36F79719D0246-36C77025N0077
Award Date
9/11/25
Potential Completion Date
9/22/25
Potential Value
$144K
Funding Federal Agency
Veterans Integrated Service Network 12
Contracting Federal Agency
Veterans Integrated Service Network 15
Awardee
Merz Pharmaceuticals, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raleigh, NC 27615, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price delivery order awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA) to Merz Pharmaceuticals, LLC, a foreign-owned for-profit organization. The contract is for the supply of LEVODOPA NDC 10144-0342-60, a pharmaceutical product, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has a ceiling value of $653,990.40 and a period of performance through October 9, 2024. This contract...
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The $478,860.00 contract is for the delivery of pharmaceutical products, specifically Levodopa 42mg inhalation capsules used to treat Parkinson's disease symptoms. The contract is associated with Acorda's Federal Supply Schedule (FSS) contract with the VA, valued...
This federal contract award, valued at $18,377.86, was issued by the U.S. Department of Veterans Affairs (VA) to Galderma Laboratories, L.P., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the procurement of 6 units of the injectable pharmaceutical product NEMOLIZUMAB CCP 30MG INJ, with a completion date of November 30, 2024. The contract is a firm fixed-price purchase order, and there were no set-aside requirements. Galderma Laboratories, L.P. has a history of...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Merck Sharp & Dohme LLC (Merck), a prominent pharmaceutical manufacturer. The contract, which is not set aside, has a ceiling value of $10,496.92 and an ultimate completion date of August 27, 2025. The contract was awarded under Merck's existing Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. This indicates that the contract is for the delivery of pharmaceutical...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The contract, valued at $478,860.00, is a Firm Fixed Price Delivery Order under Acorda's Federal Supply Schedule (FSS) contract with the VA. The contract is for the supply of Levodopa 42mg inhalation capsules, a medication used to treat Parkinson's disease, to the VA's Veterans Health Administration and Veterans...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical goods. The contract, valued at $231,396.00, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the procurement of specialized medical treatments, such as cancer therapies and advanced pharmaceuticals, to support the VA's medical programs. The contract utilizes the...
This federal contract award, valued at $95,772.00, was issued by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The contract is a delivery order under Acorda's Federal Supply Schedule (FSS) contract with the VA, which has a total value of over $16.3 million and is used to procure the company's pharmaceutical products, including Levodopa 42mg inhalation capsules for the treatment of Parkinson's disease. The...
This federal contract award is for the delivery of NEMLUVIO 30 MG, an injectable pharmaceutical product, to the Veterans Integrated Service Network 5 (VISN 5), a division of the U.S. Department of Veterans Affairs (VA). The $24,905.28 firm fixed-price contract was awarded to Galderma Laboratories, L.P., a foreign-owned, for-profit pharmaceutical manufacturer, on August 22, 2025. The contract has an ultimate completion date of August 26, 2025 and is placed under the Pharmaceuticals and Drugs...
This federal contract award, valued at $93,241.75, was issued by the Veterans Integrated Service Network 6 (VISN 6), a component of the U.S. Department of Veterans Affairs (VA), to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The contract is a Blanket Purchase Agreement (BPA) call under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows for the streamlined procurement of specialized pharmaceutical products. The contract is for...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The order is for the drug Welireg (belzutifan) 40mg tablets, National Drug Code 00006-5331-01. The award has a ceiling value of $19,964.86 and an ultimate completion date of July 10, 2024. This delivery order falls under Merck's prime contract on the...